Archives: News

News

Pfizer and BioNTech Share Positive Early Data on Vaccine Candidate Against COVID-19

– Pfizer Inc. and BioNTech SE have shared additional Phase 1 safety and immunogenicity data from their...
News

Early Findings from Fitbit COVID-19 Study Suggest Fitbit Devices Can Identify Signs of Disease at Its Earliest Stages

– Fitbit, a company that manufactures and markets health-tracking watches, announced that early results from their...
News

Regeneron and Roche Collaborate to Significantly Increase Global Supply Antibody Cocktail for COVID-19

– Regeneron Pharmaceuticals, Inc. and Roche announced that they are teaming up in the fight against...
News

GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine

– GSK and Medicago announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining...
News

Regeneron Announces Manufacturing and Supply Agreement for REGN-COV2 Anti-Viral Antibody Cocktail

– Regeneron Pharmaceuticals, Inc. announced that, as part of Operation Warp Speed, the Biomedical Advanced Research...
News

Novavax Announces $1.6 Billion Funding from Operation Warp Speed

– Novavax, Inc. received 1.6 billion from Operation Warp Speed (OWS), a U.S. government program aiming...
News

INOVIO Announces Positive Phase 1 Data For COVID-19 Vaccine

– INOVIO, a biotech company announced positive interim clinical data of INO-4800, its vaccine candidate against...
News

FDA to Help Facilitate Timely Development of Safe, Effective COVID-19 Vaccines

– FDA issues guidelines to help facilitate the timely development of safe and effective vaccines to...
News

Publication of Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity in Nano Letters

– Cellics Therapeutics, Inc. announced that the results of their study evaluating the potential benefits of...
News

FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine

– FDA has revoked the emergency use authorization (EUA) that allowed for chloroquine phosphate and hydroxychloroquine sulfate donated...
News

Dexamethasone reduces death in hospitalised patients with severe respiratory complications of COVID-19

– Oxford University study shows that low doses of a long-used steroid Dexamethasone could be the...
News

Lilly Begins a Phase 3 Clinical Trial with Baricitinib for Hospitalized COVID-19 Patients

– Eli Lilly and Company announced today the start of a Phase 3 randomized, double-blind, placebo–controlled...
News

Roche’s Elecsys IL-6 test receives FDA Emergency Use Authorization

– Roche announced that the FDA has issued an Emergency Use Authorisation for the Elecsys® IL-6...
News

Lilly Starts World’s First Study of a Potential COVID-19 Antibody Treatment in Humans

– Eli Lilly and Company announced patients have been dosed in the world's first study of...
News

LabCorp Launches New COVID-19 Clinical Trial Site

– LabCorp (NYSE: LH) announced that Covance, its drug development business, has created COVID-19 Clinical Trial...
News

Genentech Begins Phase III Clinical Trial of Actemra Plus Remdesivir for Severe COVID-19 Pneumonia

– Genentech close to completing enrollment of a global randomized, double-blind, placebo-controlled Phase III clinical trial...
News

Merck and Ridgeback Bio Collaborate on Novel Antiviral Candidate

– Merck announces collaborative agreement with Ridgeback Biotherapeutics LP, a closely held biotechnology company, to develop...
News

Merck and IAVI Collaborate to Develop Vaccine Against SARS-CoV-2

– Merck announced collaboration with IAVI, a nonprofit scientific research organization dedicated to addressing urgent, unmet...
News

CanSino Biologics and Precision NanoSystems to Co-Develop a COVID-19 RNA Vaccine

– Tianjin, China’s CanSino Biologics and Vancouver, British Columbia’s Precision NanoSystems (PNI) to co-develop an mRNA...
News

AstraZeneca COVID-19 Vaccine to be Available Beginning in October

– U.S. Department of Health and Human Services (HHS) announces collaboration of USD 1.2 billion with...

Never miss an insight

Get insights delivered right to your inbox

You have successfully subscribed to our newsletter.

Too many subscribe attempts for this email address.

*